Home Cart Sign in  
Chemical Structure| 1262041-49-5 Chemical Structure| 1262041-49-5

Structure of GS-444217
CAS No.: 1262041-49-5

Chemical Structure| 1262041-49-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

ASK1-IN-1 is an apoptosis signal regulating kinase 1 (ASK1) inhibitor.

Synonyms: ASK1-IN-1

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of GS-444217

CAS No. :1262041-49-5
Formula : C23H21N7O
M.W : 411.46
SMILES Code : O=C(NC1=CC=CC(C2=NN=CN2C3CC3)=C1)C4=NC=CC(N5C=C(C6CC6)N=C5)=C4
Synonyms :
ASK1-IN-1
MDL No. :MFCD30534397
InChI Key :ZGCMQKWOUIMBEP-UHFFFAOYSA-N
Pubchem ID :57504987

Safety of GS-444217

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of GS-444217

MAPK

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
HEK293T cells 0.001–10 μM 2 hours To evaluate the effect of GS-444217 to inhibit ASK1 autophosphorylation and ASK1-mediated signaling. GS-444217 reduced ASK1 phosphorylation and prevented the phosphorylation of MKK3/6, MKK4, p38, and JNK at concentrations of 0.3 μM and above with full suppression of ASK1 activity at 1 μM. J Clin Invest. 2018 Oct 1;128(10):4485-4500
Mouse cochlear explants 100 μM 24 hours Evaluate the effect of high concentration GS-444217 on hair cell survival. Results showed that 100 μM GS-444217 did not significantly increase hair cell death. J Mol Med (Berl). 2022 May;100(5):797-813
Mouse cochlear explants 1 μM 24 hours Evaluate the inhibitory effect of GS-444217 on aminoglycoside-induced hair cell death. Results showed that 1 μM GS-444217 significantly attenuated neomycin-induced hair cell death. J Mol Med (Berl). 2022 May;100(5):797-813

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Rats Renal ischemia/reperfusion (I/R) injury model Oral 30 mg/kg Single dose To assess the protective effect of GS-444217 against acute renal tubular injury. GS-444217 reduced serum creatinine and blood urea nitrogen, decreased tubular necrosis and apoptosis, and reduced mRNA expression of proinflammatory and profibrotic mediators. J Clin Invest. 2018 Oct 1;128(10):4485-4500
Mice Diabetic mouse model Oral gavage 30 mg/kg/bid Twice daily, from day 10 to day 28 GS-444217 treatment reduced the gene expression of Cdkn1a and Cdkn2a, and the number of Cdkn1a+ TEC in diabetic kidneys, and reduced urine excretion of Cdkn1a at day 28 after IRI. Clin Sci (Lond). 2024 Mar 6;138(5):309-326
Mice Nlrp3A350V/+CreT knock-in mice Oral 0.2% in chow Continued for 6 weeks To evaluate the effect of ASK1 inhibition on liver fibrosis, showing significant reduction in liver cell death and fibrosis JCI Insight. 2020 Jan 30;5(2):e123294
Mice Tg26 mouse model Oral 0.1% or 0.2% 6 weeks GS-444217 attenuated the development of GS, podocyte loss, tubular injury, interstitial inflammation and renal fibrosis in Tg26 mice. These improvements were accompanied by a marked reduction in albuminuria and improved renal function. Nephrol Dial Transplant. 2021 Feb 20;36(3):430-441
SD rats and WKY rats Nephrotoxic serum nephritis (NTN) model Oral gavage 30 mg/kg Twice daily, until 1 hour before being killed (day 1 for SD rats, day 14 for WKY rats) GS-444217 inhibited p38 and JNK signaling pathways, reducing kidney inflammation and fibrosis. In SD rats, GS-444217 prevented proteinuria and glomerular thrombosis with suppression of macrophage activation. In WKY rats, GS-444217 reduced crescent formation, prevented renal impairment and reduced proteinuria. J Cell Mol Med. 2018 Sep;22(9):4522-4533

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.43mL

0.49mL

0.24mL

12.15mL

2.43mL

1.22mL

24.30mL

4.86mL

2.43mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories